Table 6.

Randomized Controlled Trials Comparing Outcomes of Endoscopic Sphincterotomy (ES) Laparoscopic Common Duct Exploration (Lap.), and Laparo-Endoscopic Rendezvous Technique (Lap.-ES), 2001–2010.

Author Intervention Mean Age y (range or SD) Pts. n Stone Clearance n (%)* Additional CBDI needed (ES or Surg.) n (%) Minor and Major Complications n (%) Mortality n (%) Length of Hospital Stay d (mean or mean range) Author Conclusions
Sgourakis and Karaliotas (2002)46 ES 46–89 42 27/32 (84.3) 5/42 (11.9) 6/42 (14.3) 1/42 (2.4) 9.0 There is a need for further randomized trials
Lap. 43–88 36 24/28 (85.7) 4/36 (11.1) 5/36 (13.9) 1/36 (2.8) 7.4

Hong et al. (2006)47 ES Not given 93 85/93 (91.4) 8/93 (8.6) 9/93 (9.4) 0 (0.0) 4.3 ES and Lap. are safe and effective treatments for CBD stones
Lap. 48 (15–82) 141 126/141 (89.4) 15/141 (10.6) 8/141 (5.6) 0 (0.0) 4.7

Lella et al. (2006)52 ES Not given (<60) 60 58/60 (96.7) 0/60 (0.0) 8/60 (13.3) 0 (0.0) 6 Lap.-ES prevents post-ES pancreatitis in patients at risk for this complication
Lap.-ES Not given (<60) 60 59/60 (98.3) 2/60 (3.3) 2/60 (3.3) 0 (0.0) 3

Morino et al. (2006)4 ES 63.1 (25–83) 45 9/45 (80.0) 17/45 (37.8) 3/45 (6.6) 0 (0.0) 8.0 Lap.-ES carries a higher rate of CBD stones clearance and shorter hospital stays than ES
Lap.-ES 56.6 (22–82) 46 44/46 (95.6) 3/46 (6.5) 3/46 (6.5) 0 (0.0) 4.3

Rábago et al. (2006)51 ES Not given (<80) 64 28/31 (90.5) 7/64 (10.9) 12/64 (18.8) 0 (0.0) 8 Lap.-ES had less morbidity and a shorter hospital stay than ES
Lap.-ES Not given (<80) 59 20/25 (80.0) 4/59 (6.8) 3/59 (5.1) 0 (0.0) 5

Noble et al. (2009)48 ES 74.3 (70–79) 47 26/46 (56.5) 2/47 (4.3) 8/47 (17.0) 0 (0.0) 3 No difference in hospital stay, complications, or conversion. Lap. was more effective and avoided unnecessary procedures
Lap. 75.9 (70–81) 44 38/38 (100) 4/44 (9.1) 8/44 (18.2) 0 (0.0) 5

Bansal et al. (2010)50 ES 39.1 (23–64) 15 11/15 (73.3) 2/15 (13.3) 4/15 (26.7) 0 (0.0) 4.0 Equivalent morbidity and hospital stay. Lap. carried a smaller number of procedures
Lap. 47.1 (34–72) 15 14/15 (93.3) 1/15 (6.7) 4/15 (26.7) 0 (0.0) 4.2

Rogers et al. (2010)49 ES 44.6±1.9 55 30/31 (98) 1/55 (1.8) 5/55 (9.1) 0 (0.0) 6.6 ES and Lap. are highly effective in treating CBD stones. Hospital stay was shorter for Lap.
Lap. 39.9±1.9 57 15/17 (88) 2/57 (3.5) 6/57 (10.5) 0 (0.0) 5.3

Total ES 421 274/353 (77.6) 42/421 (9.8) 55/421 (13/1) 1/421 (0.2) 3–9
Lap. 293 217/239 (90.8) 26/293 (8.9) 31/293 (10.6) 1/293 (0.3) 4.2–7.4
Lap.-ES 165 123/131 (93.9) 9/165 (5.5) 8/165 (4.8) 0/165 (0.0) 3–5
* The denominators include the total number of patients entered into the trial, after excluding those with suspected but absent CBD stones.
† The denominators include the number of patients with available data.

CBDI, common bile duct interventions; d, day(s); Pts., patients; y, year(s).

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2024 April; 15(2): e0007. ISSN: 2076-9172
Published online 2024 April 28. doi: 10.5041/RMMJ.10521